Nebulized morphine for relief of dyspnea due to chronic lung disease.
To evaluate the efficacy and safety of nebulized morphine for the management of dyspnea in chronic pulmonary diseases. MEDLINE (1966-May 2004), EMBASE (1980-May 2004), and International Pharmaceutical Abstracts (1970-May 2004) searches were performed. Key search terms included morphine, dyspnea, and inhalation. Nine studies have evaluated the efficacy of nebulized morphine in relieving dyspnea. Three trials had positive results, but the rest failed to show improvement after treatment with doses ranging from 1 to 40 mg nebulized morphine. The small number of subjects, variety of disease states, and different outcome measures limit interpretation of the studies. Results from several small studies do not support the use of nebulized morphine for treatment of dyspnea; however, several positive case reports have been published.